fda drug shortages semaglutide injection shortage resolved 2025 Hims & Hers stock falls 25% as curtails compounded GLP-1s FDA Declares Shortage of Novo

For patients with knee osteoarthritis, the pain relief demonstrated in TRIUMPH-4 could mean the difference between mobility and disability

Here is how those variables fit together as of April 2026, reported as published rather than as any guarantee

Medicare GLP-1 Bridge Program for Weight Loss in Merrillville At Way Less Weight Loss Clinic in Merrillville, Indiana, we help eligible Medicare patients navigate the Medicare GLP-1 Bridge Program and access GLP-1 weight loss medications when they meet CMS eligibility requirements

Target total daily intake of 80 ounces minimum

These studies provide preliminary evidence of BPC 157's potential benefits in various pathologies

But you may be less familiar with semaglutide , the active ingredient behind these two brand-name drugs (as well as another medication, called Rybelsus)